Prognostic value of pro-inflammatory markers at the preoperative stage in Algerian women with breast cancer

[1] The Global Cancer Observatory - All Rights Reserved - March, 2021. The Global Cancer Observatory - All Rights Reserved - March, 2021 Search in Google Scholar

[2] Liu, X., et al., Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies. Genes Dis, 2023. 10(1): p. 151–164. LiuX. Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies Genes Dis 2023 10 1 151 164 Search in Google Scholar

[3] Tuomisto, A.E., M.J. Mäkinen, and J.P. Väyrynen, Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance. World J Gastroenterol, 2019. 25(31): p. 4383–4404. TuomistoA.E. MäkinenM.J. VäyrynenJ.P. Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance World J Gastroenterol 2019 25 31 4383 4404 Search in Google Scholar

[4] Wall, I., et al., Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood. Cancers (Basel), 2022. 14(18). WallI. Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood Cancers (Basel) 2022 14 18 Search in Google Scholar

[5] Shaul, M.E. and Z.G. Fridlender, Neutrophils as active regulators of the immune system in the tumor microenvironment. J Leukoc Biol, 2017. 102(2): p. 343–349. ShaulM.E. FridlenderZ.G. Neutrophils as active regulators of the immune system in the tumor microenvironment J Leukoc Biol 2017 102 2 343 349 Search in Google Scholar

[6] Kehm, R.D., et al., Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research. Int J Environ Res Public Health, 2020. 17(15). KehmR.D. Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research Int J Environ Res Public Health 2020 17 15 Search in Google Scholar

[7] Ghasemzadeh, M. and E. Hosseini, Intravascular leukocyte migration through platelet thrombi: directing leukocytes to sites of vascular injury. Thromb Haemost, 2015. 113(6): p. 1224–35. GhasemzadehM. HosseiniE. Intravascular leukocyte migration through platelet thrombi: directing leukocytes to sites of vascular injury Thromb Haemost 2015 113 6 1224 35 Search in Google Scholar

[8] Gao, G., et al., Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis. BMC Cancer, 2020. 20(1): p. 179. GaoG. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis BMC Cancer 2020 20 1 179 Search in Google Scholar

[9] Fogar, P., et al., Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas, 2006. 32(1): p. 22–8. FogarP. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome Pancreas 2006 32 1 22 8 Search in Google Scholar

[10] Wangchinda, P. and S. Ithimakin, Factors that predict recurrence later than 5 years after initial treatment in operable breast cancer. World J Surg Oncol, 2016. 14(1): p. 223. WangchindaP. IthimakinS. Factors that predict recurrence later than 5 years after initial treatment in operable breast cancer World J Surg Oncol 2016 14 1 223 Search in Google Scholar

[11] Ramos-Esquivel, A., L. Rodriguez-Porras, and J. Porras, Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in non-metastatic breast cancer patients from a Hispanic population. Breast Dis, 2017. 37(1): p. 1–6. Ramos-EsquivelA. Rodriguez-PorrasL. PorrasJ. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in non-metastatic breast cancer patients from a Hispanic population Breast Dis 2017 37 1 1 6 Search in Google Scholar

[12] Duan, J., L. Pan, and M. Yang, Preoperative elevated neutrophil-to-lymphocyte ratio (NLR) and derived NLR are associated with poor prognosis in patients with breast cancer: A meta-analysis. Medicine (Baltimore), 2018. 97(49): p. e13340. DuanJ. PanL. YangM. Preoperative elevated neutrophil-to-lymphocyte ratio (NLR) and derived NLR are associated with poor prognosis in patients with breast cancer: A meta-analysis Medicine (Baltimore) 2018 97 49 e13340 Search in Google Scholar

[13] Al Jarroudi, O., et al., Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer. Biomark Med, 2021. 15(14): p. 1289–1298. Al JarroudiO. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer Biomark Med 2021 15 14 1289 1298 Search in Google Scholar

[14] Guo, W., et al., Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals. Cancer Med, 2019. 8(9): p. 4135–4148. GuoW. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals Cancer Med 2019 8 9 4135 4148 Search in Google Scholar

[15] Hsieh, M.M., et al., Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med, 2007. 146(7): p. 486–92. HsiehM.M. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences Ann Intern Med 2007 146 7 486 92 Search in Google Scholar

[16] Azab, B., M. Camacho-Rivera, and E. Taioli, Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects. PLoS One, 2014. 9(11): p. e112361. AzabB. Camacho-RiveraM. TaioliE. Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects PLoS One 2014 9 11 e112361 Search in Google Scholar

[17] Zenan, H., et al., Clinical prognostic evaluation of immunocytes in different molecular subtypes of breast cancer. J Cell Physiol, 2019. 234(11): p. 20584–20602. ZenanH. Clinical prognostic evaluation of immunocytes in different molecular subtypes of breast cancer J Cell Physiol 2019 234 11 20584 20602 Search in Google Scholar

[18] Truffi, M., et al., Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2‒ Early Breast Cancer. Front Oncol, 2021. 11: p. 773078. TruffiM. Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2‒ Early Breast Cancer Front Oncol 2021 11 773078 Search in Google Scholar

[19] Orditura, M., et al., Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis. ESMO Open, 2016. 1(2): p. e000038. OrdituraM. Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis ESMO Open 2016 1 2 e000038 Search in Google Scholar

[20] Hu, R.J., et al., Preoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: A meta-analysis. Clin Chim Acta, 2018. 484: p. 1–6. HuR.J. Preoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: A meta-analysis Clin Chim Acta 2018 484 1 6 Search in Google Scholar

[21] Patel, A.A. and S. Yona, Inherited and Environmental Factors Influence Human Monocyte Heterogeneity. Front Immunol, 2019. 10: p. 2581. PatelA.A. YonaS. Inherited and Environmental Factors Influence Human Monocyte Heterogeneity Front Immunol 2019 10 2581 Search in Google Scholar

[22] Coates, S., et al., Time- and Race-Specific Haematological Reference Intervals for Healthy Volunteer Trials: A Retrospective Analysis of Pooled Data From Multiple Phase I Trials. Front Pharmacol, 2020. 11: p. 314. CoatesS. Time- and Race-Specific Haematological Reference Intervals for Healthy Volunteer Trials: A Retrospective Analysis of Pooled Data From Multiple Phase I Trials Front Pharmacol 2020 11 314 Search in Google Scholar

[23] He, J., et al., Prognostic Significance of Preoperative Lactate Dehydrogenase to Albumin Ratio in Breast Cancer: A Retrospective Study. Int J Gen Med, 2023. 16: p. 507–514. HeJ. Prognostic Significance of Preoperative Lactate Dehydrogenase to Albumin Ratio in Breast Cancer: A Retrospective Study Int J Gen Med 2023 16 507 514 Search in Google Scholar

[24] Zhang, Y., Y. Sun, and Q. Zhang, Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis. Cancer Cell Int, 2020. 20: p. 224. ZhangY. SunY. ZhangQ. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis Cancer Cell Int 2020 20 224 Search in Google Scholar

[25] Li, W., et al., Systemic Immune-Inflammation Index Is a Prognostic Factor for Breast Cancer Patients After Curative Resection. Front Oncol, 2021. 11: p. 570208. LiW. Systemic Immune-Inflammation Index Is a Prognostic Factor for Breast Cancer Patients After Curative Resection Front Oncol 2021 11 570208 Search in Google Scholar

[26] Wang, L., et al., Prognostic value of the systemic inflammation response index (SIRI) before and after surgery in operable breast cancer patients. Cancer Biomark, 2020. 28(4): p. 537–547. WangL. Prognostic value of the systemic inflammation response index (SIRI) before and after surgery in operable breast cancer patients Cancer Biomark 2020 28 4 537 547 Search in Google Scholar

[27] Hua, X., et al., The preoperative systemic inflammation response index (SIRI) independently predicts survival in postmenopausal women with breast cancer. Curr Probl Cancer, 2020. 44(4): p. 100560. HuaX. The preoperative systemic inflammation response index (SIRI) independently predicts survival in postmenopausal women with breast cancer Curr Probl Cancer 2020 44 4 100560 Search in Google Scholar

[28] Jiang, C., et al., The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Clin Breast Cancer, 2022. 22(5): p. 424–438. JiangC. The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Clin Breast Cancer 2022 22 5 424 438 Search in Google Scholar

[29] Guthrie, G.J., et al., The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol, 2013. 88(1): p. 218–30. GuthrieG.J. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer Crit Rev Oncol Hematol 2013 88 1 218 30 Search in Google Scholar

[30] Cho, U., et al., Prognostic Role of Systemic Inflammatory Markers in Patients Undergoing Surgical Resection for Oral Squamous Cell Carcinoma. Biomedicines, 2022. 10(6). ChoU. Prognostic Role of Systemic Inflammatory Markers in Patients Undergoing Surgical Resection for Oral Squamous Cell Carcinoma Biomedicines 2022 10 6 Search in Google Scholar

[31] Noh, H., M. Eomm, and A. Han, Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients. J Breast Cancer, 2013. 16(1): p. 55–9. NohH. EommM. HanA. Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients J Breast Cancer 2013 16 1 55 9 Search in Google Scholar

[32] Ethier, J.L., et al., Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res, 2017. 19(1): p. 2. EthierJ.L. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis Breast Cancer Res 2017 19 1 2 Search in Google Scholar

[33] Jia, W., et al., The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients. PLoS One, 2015. 10(11): p. e0143061. JiaW. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients PLoS One 2015 10 11 e0143061 Search in Google Scholar

[34] Kauffmann-Guerrero, D., et al., Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study. Sci Rep, 2021. 11(1): p. 10919. Kauffmann-GuerreroD. Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study Sci Rep 2021 11 1 10919 Search in Google Scholar

[35] Wariss, B.R., et al., Effectiveness of four inflammatory markers in predicting prognosis in 2374 women with breast cancer. Maturitas, 2017. 101: p. 51–56. WarissB.R. Effectiveness of four inflammatory markers in predicting prognosis in 2374 women with breast cancer Maturitas 2017 101 51 56 Search in Google Scholar

[36] Gong, Z., et al., Platelet-to-lymphocyte ratio associated with the clinicopathological features and prognostic value of breast cancer: A meta-analysis. Int J Biol Markers, 2022. 37(4): p. 339–348. GongZ. Platelet-to-lymphocyte ratio associated with the clinicopathological features and prognostic value of breast cancer: A meta-analysis Int J Biol Markers 2022 37 4 339 348 Search in Google Scholar

[37] Onagi, H., et al., High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs. Breast Cancer Res, 2022. 24(1): p. 67. OnagiH. High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs Breast Cancer Res 2022 24 1 67 Search in Google Scholar

[38] Olsson, A.K. and J. Cedervall, NETosis in Cancer - Platelet-Neutrophil Crosstalk Promotes Tumor-Associated Pathology. Front Immunol, 2016. 7: p. 373. OlssonA.K. CedervallJ. NETosis in Cancer - Platelet-Neutrophil Crosstalk Promotes Tumor-Associated Pathology Front Immunol 2016 7 373 Search in Google Scholar

[39] Labelle, M., S. Begum, and R.O. Hynes, Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci U S A, 2014. 111(30): p. E3053–61. LabelleM. BegumS. HynesR.O. Platelets guide the formation of early metastatic niches Proc Natl Acad Sci U S A 2014 111 30 E3053 61 Search in Google Scholar

[40] Gonzalez-Aparicio, M. and C. Alfaro, Influence of Interleukin-8 and Neutrophil Extracellular Trap (NET) Formation in the Tumor Microenvironment: Is There a Pathogenic Role? J Immunol Res, 2019. 2019: p. 6252138. Gonzalez-AparicioM. AlfaroC. Influence of Interleukin-8 and Neutrophil Extracellular Trap (NET) Formation in the Tumor Microenvironment: Is There a Pathogenic Role? J Immunol Res 2019 2019 6252138 Search in Google Scholar

[41] Ronchetti, L., et al., Neutrophil extracellular traps in cancer: not only catching microbes. J Exp Clin Cancer Res, 2021. 40(1): p. 231. RonchettiL. Neutrophil extracellular traps in cancer: not only catching microbes J Exp Clin Cancer Res 2021 40 1 231 Search in Google Scholar

[42] Gerratana, L., et al., Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis. Sci Rep, 2020. 10(1): p. 7010. GerratanaL. Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis Sci Rep 2020 10 1 7010 Search in Google Scholar

[43] Liu, Y., et al., Relationship between lymphocyte to monocyte ratio and brain metastasis in non-smalll cell lung cancer patients. Am J Transl Res, 2022. 14(6): p. 3936–3945. LiuY. Relationship between lymphocyte to monocyte ratio and brain metastasis in non-smalll cell lung cancer patients Am J Transl Res 2022 14 6 3936 3945 Search in Google Scholar

[44] Zergoun, A.A., et al., Plasma secretome analyses identify IL-8 and nitrites as predictors of poor prognosis in nasopharyngeal carcinoma patients. Cytokine, 2022. 153: p. 155852. ZergounA.A. Plasma secretome analyses identify IL-8 and nitrites as predictors of poor prognosis in nasopharyngeal carcinoma patients Cytokine 2022 153 155852 Search in Google Scholar

[45] Lu, X., et al., Serum CCL2 and serum TNF-α--two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma. Eur J Cancer, 2011. 47(3): p. 339–46. LuX. Serum CCL2 and serum TNF-α--two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma Eur J Cancer 2011 47 3 339 46 Search in Google Scholar

[46] Guo, H., et al., Knockdown of Notch1 inhibits nasopharyngeal carcinoma cell growth and metastasis via downregulation of CCL2, CXCL16, and uPA. Mol Carcinog, 2019. 58(10): p. 1886–1896. GuoH. Knockdown of Notch1 inhibits nasopharyngeal carcinoma cell growth and metastasis via downregulation of CCL2, CXCL16, and uPA Mol Carcinog 2019 58 10 1886 1896 Search in Google Scholar

[47] Jin, J., et al., CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment. Front Oncol, 2021. 11: p. 722916. JinJ. CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment Front Oncol 2021 11 722916 Search in Google Scholar

[48] Güç, E. and J.W. Pollard, Redefining macrophage and neutrophil biology in the metastatic cascade. Immunity, 2021. 54(5): p. 885–902. GüçE. PollardJ.W. Redefining macrophage and neutrophil biology in the metastatic cascade Immunity 2021 54 5 885 902 Search in Google Scholar

[49] Kumar, V. and A. Sharma, Neutrophils: Cinderella of innate immune system. Int Immunopharmacol, 2010. 10(11): p. 1325–34. KumarV. SharmaA. Neutrophils: Cinderella of innate immune system Int Immunopharmacol 2010 10 11 1325 34 Search in Google Scholar

[50] Rubenich, D.S., et al., Tumor-neutrophil crosstalk promotes in vitro and in vivo glioblastoma progression. Front Immunol, 2023. 14: p. 1183465. RubenichD.S. Tumor-neutrophil crosstalk promotes in vitro and in vivo glioblastoma progression Front Immunol 2023 14 1183465 Search in Google Scholar

[51] Bun, A., et al., Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating Lymphocytes. Anticancer Res, 2020. 40(5): p. 2871–2880. BunA. Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating Lymphocytes Anticancer Res 2020 40 5 2871 2880 Search in Google Scholar